Last edition
News about "Aurobindo Pharma USA "
Aurobindo Pharma USA Completes Acquisition of Lannett Company
Aurobindo Pharma USA has completed the acquisition of Lannett Company after securing approval from the US Federal Trade Commission. Effective June 29, 2026, Lannett will operate as Lannett Company LLC, with the combined entity aiming to strengthen the supply of essential medicines and enhance value for patients and customers.
Aurobindo Pharma USA | 30/06/2026 | By News Bureau
Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company
Aurobindo Pharma USA receives FTC approval to acquire Lannett Company in a USD 250 million deal. The transaction is expected to close before the end of June 2026.
Aurobindo Pharma USA | 22/06/2026 | By News Bureau
Aurobindo Pharma USA To Acquire Lannett For USD 250 Million, Enter ADHD Treatment Space
Aurobindo Pharma USA Inc., has entered into a definitive agreement to acquire 100 percent membership interest in Lannett Company LLC from its parent company, Lannett Seller Holdco, Inc.
Aurobindo Pharma USA | 31/07/2025 | By Dineshwori | 628
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy